Application 077099

Type
ANDA
Sponsor
VINTAGE PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ORSYTHIAETHINYL ESTRADIOL; LEVONORGESTRELTABLET;ORAL-280.02MG;0.1MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077099-001ORSYTHIAETHINYL ESTRADIOL; LEVONORGESTREL0.02MG;0.1MGTABLET / ORAL-282011-05-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A077099-001ORSYTHIA0.02MG;0.1MGTABLET / ORAL-282011-05-113a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A077099-001ORSYTHIA0.02MG;0.1MGTABLET / ORAL-282011-05-11f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A077099-001ORSYTHIA0.02MG;0.1MGTABLET / ORAL-282011-05-11e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A077099-001ORSYTHIA0.02MG;0.1MGTABLET / ORAL-282011-05-11cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A077099-001ORSYTHIA0.02MG;0.1MGTABLET / ORAL-282011-05-11a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12A077099-001AB1174a2ff9319b5…
2019-12-14 00:12 UTC2019-12A077099-001AB113f01610625f2…
2019-09-15 20:21 UTC2019-09A077099-001AB11b00525d2431f…
2019-07-19 19:46 UTC2019-07A077099-001AB11ea99ee380514…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0603-7634Orsythialevonorgestrel and ethinyl estradiolPar PharmaceuticalANDACurrent
0603-7634Orsythialevonorgestrel and ethinyl estradiolPar PharmaceuticalANDACurrent
50090-1380Orsythialevonorgestrel and ethinyl estradiolA-S Medication SolutionsANDACurrent
53002-1647Orsythialevonorgestrel and ethinyl estradiolRPK Pharmaceuticals, Inc.ANDACurrent
53002-1647Orsythialevonorgestrel and ethinyl estradiolRPK Pharmaceuticals, Inc.ANDACurrent